z-logo
open-access-imgOpen Access
Depression in vascular pathologies: the neurologist's point of view
Author(s) -
Rita Moretti,
Elena Bernobich,
Francesca Esposito,
Paola Torre,
Antonello Rodolfo,
L. de Angelis,
Giuseppe Bellini
Publication year - 2011
Publication title -
vascular health and risk management
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.892
H-Index - 68
eISSN - 1178-2048
pISSN - 1176-6344
DOI - 10.2147/vhrm.s20147
Subject(s) - medicine , depression (economics) , pathophysiology , endothelial dysfunction , disease , stroke (engine) , thrombosis , myocardial infarction , vascular disease , cardiology , bioinformatics , intensive care medicine , neuroscience , mechanical engineering , biology , engineering , economics , macroeconomics
The coexistence of depression and cardiovascular disease (CVD) is regularly discussed, and much debated. There is strong evidence that there are pathophysiological mechanisms, particularly endothelial dysfunction, altered platelet aggregation, and hyperactivation of the thrombosis cascade, which coexist with hypothalamic-pituitary-adrenocortical axis dysfunction, and link depression to CVD. Therefore, depression should not be automatically considered to be a consequence of life impairment due to myocardial infarction or major stroke. Probably, it should be considered as one of the many other stressful events, or "genetic reactions to life", which are risk factors for CVD development. This review will examine the significance of depression in clinical daily practice, its pathophysiology as a determinant in vascular events, and its real importance in, before, and after many CVD events.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom